Back to News
Market Impact: 0.2
Lupin Secures FDA Nod For Vitamin K Injection
Source: Nasdaq
Healthcare & BiotechProduct LaunchesRegulation & LegislationCompany Fundamentals
The U.S. FDA approved Lupin Limited's Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL single-dose prefilled syringe. Lupin said the approval adds another product to its U.S. injectable medicines portfolio; the article gives no sales or market-impact estimates.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
- Elon Musk intensifies attack on Ambani over Starlink India launch delay
- Wall Street Week | Michigan Manufacturing, AI Debt Investments, Baby Bonds, Canadian Coal Fight
- SpaceX’s Wireless Threat Rises With Spectrum Deal
- ‘Piece by piece’: Trump administration vows to dismantle the International Criminal Court with sweeping new sanctions
- Tesla drops 'Full Self-Driving' brand name in Europe after regulator pushback